Sun Pharma forays into health tech with investments in Agatsa Software and Remedio

Sun Pharma forays into health tech with investments in Agatsa Software and Remedio

The acquisitions will boost the pharma giant's investments in digital healthcare.

FPJ Web DeskUpdated: Saturday, February 18, 2023, 08:05 PM IST
article-image
Image: Sun Pharma (Representative)

According to a regulatory filing, Sun Pharma has acquired 26.09 per cent stake in Agatsa Software to boost digital diagnostics.

It has also bagged a 27.39 per cent stake in Remedio Innovative Solutions, for eye disease detection.

(To receive our E-paper on WhatsApp daily, please click here.  To receive it on Telegram, please click here. We permit sharing of the paper's PDF on WhatsApp and other social media platforms.)

RECENT STORIES

WABAG to Design, Build, Operate 270 MLD Water Treatment Plant Of Rs 420 Cr In Maharashtra

WABAG to Design, Build, Operate 270 MLD Water Treatment Plant Of Rs 420 Cr In Maharashtra

Mazuti Suzuki India Launches Off-Roader Jimmy At A Starting Range Of ₹1,274,000

Mazuti Suzuki India Launches Off-Roader Jimmy At A Starting Range Of ₹1,274,000

Jonnie Walker-maker Diageo's CEO Ivan Menezes Passes Away

Jonnie Walker-maker Diageo's CEO Ivan Menezes Passes Away

China exports in May fall to 7.6%, adding to signs economic recovery is slowing

China exports in May fall to 7.6%, adding to signs economic recovery is slowing

BSE And NSE Raise Price Band of 4 Adani Group Companies

BSE And NSE Raise Price Band of 4 Adani Group Companies